Attention Deficit Hyperactivity Disorder (ADHD) is increasingly recognized in both clinical and public spheres, but it is far from a new condition. Historical accounts suggest early awareness of ADHD-like behaviors, with one of the earliest descriptions attributed to Scottish physician Sir Alexander Crichton in the late 1700s. Additionally, German physician Heinrich Hoffmann’s 1840s character “Zappelphilipp” (translated as “Fidgety Phil”) illustrated traits that closely align with today’s understanding of ADHD.

Throughout the 19th century, medical literature referred to similar behaviors using terms such as “nervous child syndrome” or “mental instability.” By the 1930s, stimulant medications like amphetamines were introduced to manage symptoms now associated with ADHD. A notable milestone in ADHD treatment was the development of methylphenidate by Swiss chemist Leandro Panizzon. He named the medication “Ritaline” (Ritalin in the U.S.) after his wife, Marguerite (“Rita”), who was among the first to try it.

Despite this long history of observation and treatment, contemporary discourse around ADHD, particularly on social media, raises concerns about the over-medicalization of common behavioral traits. Platforms like TikTok have contributed to a surge in self-diagnosed ADHD cases, often based on generalized or misleading content. A recent analysis of 100 popular ADHD-related TikTok videos found that over half contained inaccurate or misleading information, while only about 20% provided content considered clinically useful. Similar trends have been observed in content related to Autism Spectrum Disorder.

While increased visibility has reduced stigma and helped many people identify with ADHD traits, it also presents risks. Social media influencers often highlight the positive aspects of ADHD, portraying distractibility as curiosity, hyperactivity as energy, and impulsiveness as creativity. While such reframing can be empowering, it can also create unrealistic expectations. What helps one individual may not help another, and the lack of nuance in online content can lead to frustration or a sense of inadequacy when suggested strategies fail.

Treatment for ADHD should be personalized and comprehensive. The medical model typically includes stimulant or non-stimulant medications, which work by increasing levels of dopamine and norepinephrine to improve attention and impulse control. For many, medication can be a critical part of symptom management. However, effective ADHD care also includes behavioral interventions. Cognitive-behavioral therapy (CBT), executive functioning coaching, and mindfulness-based strategies can significantly improve functioning and quality of life.

Emerging research has also explored the role of nutritional supplements in managing ADHD symptoms. Some studies suggest potential benefits from Omega-3 fatty acids, melatonin, zinc, magnesium, carnitine, iron, and probiotics. While promising, these interventions should be viewed as part of a larger treatment strategy rather than standalone solutions.

Ultimately, the goal of ADHD treatment is not to make individuals “think like neurotypicals,” but to help them develop internal and external strategies for navigating how their brains process information. With accurate information, professional guidance, and a personalized approach, individuals with ADHD can thrive in both their personal and professional lives.